Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

Autor: Chiappella, Annalisa, Martelli, Maurizio, Angelucci, Emanuele, Brusamolino, Ercole, Evangelista, Andrea, Carella, Angelo Michele, Stelitano, Caterina, Rossi, Giuseppe, Balzarotti, Monica, Merli, Francesco, Gaidano, Gianluca, Pavone, Vincenzo, Rigacci, Luigi, Zaja, Francesco, D'Arco, Alfonso, Cascavilla, Nicola, Russo, Eleonora, Castellino, Alessia, Gotti, Manuel, Congiu, Angela Giovanna, Cabras, Maria Giuseppina, Tucci, Alessandra, Agostinelli, Claudio, Ciccone, Giovannino, Pileri, Stefano A, Vitolo, Umberto
Zdroj: In The Lancet Oncology August 2017 18(8):1076-1088
Databáze: ScienceDirect